Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
NextFerm develops and produces active ingredients for the food industry. Its products are based on a combination of intellectual property and proprietary know-how in areas including non-GMO technologies and methodologies for enhancing specific characteristics of yeast strains isolated from nature; downstream processing, purification, extraction, and formulation; and clinical research and regulatory work.
The company is currently producing natural astaxanthin from yeast fermentation for human nutrition, implementing its yeast strain improvement technology on a strain that naturally expresses astaxanthin in order to make it a better source. Coupled with downstream engineering and clinical work, this technology results in a product with higher potency, improved flowability, and no odor or flavor in either liquid or powder form.
NextFerms goal is to develop exclusive active ingredients for the global nutrition market, including carotenoids, prebiotics, and proteins. In addition, NextFerm has developed a novel yeast strain for more efficient production of ethanol from corn mash.